Autopsy report · NCT03701074
Randomized Controlled Trial to Evaluate the Safety and Efficacy of Acetaminophen in Preterm Infants Used in Combination With Ibuprofen for Closure of the Ductus Arteriosus
Cause of deathSlow enrollment, also staffing, sites or logistics
“very slow enrollment. Only one patient enrolled. Termination by PI”
Life of this trial
- Registered 4 months before it started.
- Ran for about 2 years before it stopped.
- 1 participant enrolled.
- Results were posted on the registry 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of South Alabama
- Sponsor type
- University, hospital or other
- Conditions
- Patent Ductus Arteriosus; Preterm Infant; Bronchopulmonary Dysplasia
- Interventions
- Ibuprofen and acetaminophen; Ibuprofen and placebo
- Participants
- 1
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Use of a Loading Dose of Vancomycin in Pediatric Dosing
“PI leaving institution, slow enrollment” - Use of 3M Cavilon Advanced Skin Protectant in the Management of Damaged Skin Around an Ostomy, Drain or Fistula
“Slow enrollment of patients” - Etanercept (Enbrel) for Juvenile Myelomonocytic Leukemia
“Slow enrollment; study terminated.” - Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection
“termination due to futility (very slow patient enrollment)” - Assess Specific Kinds of Children Challenges for Neurologic Devices Study
“Slow enrollment”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.